Ortivus AB (publ) (ORTI-A.ST)
SEK 3.16
(0.0%)
SEK 3.16
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 12.45 Million SEK | -13.46% |
| 2022 | 14.39 Million SEK | 201.38% |
| 2021 | 4.77 Million SEK | 36.92% |
| 2020 | 3.48 Million SEK | -13.08% |
| 2019 | 4.01 Million SEK | 1.83% |
| 2018 | 3.94 Million SEK | 17.39% |
| 2017 | 3.35 Million SEK | 11.67% |
| 2016 | 3 Million SEK | -23.15% |
| 2015 | 3.91 Million SEK | -62.48% |
| 2014 | 10.42 Million SEK | 72.56% |
| 2013 | 6.04 Million SEK | -23.2% |
| 2012 | 7.86 Million SEK | -14.62% |
| 2011 | 9.21 Million SEK | 46.31% |
| 2010 | 6.29 Million SEK | -34.17% |
| 2009 | 9.56 Million SEK | -19.73% |
| 2008 | 11.92 Million SEK | -6.11% |
| 2007 | 12.69 Million SEK | 19.76% |
| 2006 | 10.6 Million SEK | 34.1% |
| 2005 | 7.9 Million SEK | 41.36% |
| 2004 | 5.59 Million SEK | 16.3% |
| 2003 | 4.8 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 13.64 Million SEK | 9.55% |
| 2024 Q2 | 10.46 Million SEK | -23.36% |
| 2023 FY | 12.45 Million SEK | -13.46% |
| 2023 Q1 | 17.13 Million SEK | 18.99% |
| 2023 Q2 | 12.69 Million SEK | -25.88% |
| 2023 Q3 | 16.99 Million SEK | 33.82% |
| 2023 Q4 | 12.45 Million SEK | -26.68% |
| 2022 Q4 | 14.39 Million SEK | 3.49% |
| 2022 FY | 14.39 Million SEK | 201.38% |
| 2022 Q3 | 13.91 Million SEK | 27.4% |
| 2022 Q1 | 5.27 Million SEK | 10.36% |
| 2022 Q2 | 10.92 Million SEK | 107.13% |
| 2021 FY | 4.77 Million SEK | 36.92% |
| 2021 Q3 | 4.81 Million SEK | -16.06% |
| 2021 Q1 | 4.47 Million SEK | 28.37% |
| 2021 Q2 | 5.74 Million SEK | 28.15% |
| 2021 Q4 | 4.77 Million SEK | -0.85% |
| 2020 Q3 | 3.82 Million SEK | -66.58% |
| 2020 Q1 | 3.14 Million SEK | -21.67% |
| 2020 Q2 | 11.44 Million SEK | 264.09% |
| 2020 FY | 3.48 Million SEK | -13.08% |
| 2020 Q4 | 3.48 Million SEK | -8.81% |
| 2019 Q1 | 3.55 Million SEK | -9.92% |
| 2019 FY | 4.01 Million SEK | 1.83% |
| 2019 Q2 | 4.79 Million SEK | 34.92% |
| 2019 Q3 | 4.5 Million SEK | -5.99% |
| 2019 Q4 | 4.01 Million SEK | -10.88% |
| 2018 Q1 | 3.63 Million SEK | 8.37% |
| 2018 Q4 | 3.94 Million SEK | 0.61% |
| 2018 FY | 3.94 Million SEK | 17.39% |
| 2018 Q3 | 3.91 Million SEK | 29.14% |
| 2018 Q2 | 3.03 Million SEK | -16.63% |
| 2017 Q1 | 3.55 Million SEK | 18.26% |
| 2017 Q2 | 3.48 Million SEK | -2.0% |
| 2017 Q4 | 3.35 Million SEK | -0.36% |
| 2017 FY | 3.35 Million SEK | 11.67% |
| 2017 Q3 | 3.37 Million SEK | -3.3% |
| 2016 Q2 | 4.75 Million SEK | 25.28% |
| 2016 FY | 3 Million SEK | -23.15% |
| 2016 Q1 | 3.79 Million SEK | -2.96% |
| 2016 Q4 | 3 Million SEK | -40.42% |
| 2016 Q3 | 5.04 Million SEK | 6.1% |
| 2015 Q2 | 5.44 Million SEK | -54.02% |
| 2015 Q4 | 3.91 Million SEK | -10.95% |
| 2015 Q1 | 11.84 Million SEK | 13.63% |
| 2015 FY | 3.91 Million SEK | -62.48% |
| 2015 Q3 | 4.39 Million SEK | -19.35% |
| 2014 Q4 | 10.42 Million SEK | 18.22% |
| 2014 FY | 10.42 Million SEK | 72.56% |
| 2014 Q3 | 8.82 Million SEK | -4.83% |
| 2014 Q2 | 9.26 Million SEK | 43.66% |
| 2014 Q1 | 6.45 Million SEK | 6.77% |
| 2013 Q3 | 5.48 Million SEK | -7.71% |
| 2013 Q1 | 6.32 Million SEK | -19.66% |
| 2013 Q4 | 6.04 Million SEK | 10.27% |
| 2013 FY | 6.04 Million SEK | -23.2% |
| 2013 Q2 | 5.93 Million SEK | -6.07% |
| 2012 Q1 | 13.18 Million SEK | 43.1% |
| 2012 Q2 | 9.63 Million SEK | -26.91% |
| 2012 Q3 | 7.23 Million SEK | -24.95% |
| 2012 FY | 7.86 Million SEK | -14.62% |
| 2012 Q4 | 7.86 Million SEK | 8.78% |
| 2011 Q4 | 9.21 Million SEK | -1.33% |
| 2011 FY | 9.21 Million SEK | 46.31% |
| 2011 Q1 | 5.72 Million SEK | -9.13% |
| 2011 Q2 | 7.88 Million SEK | 37.74% |
| 2011 Q3 | 9.34 Million SEK | 18.47% |
| 2010 FY | 6.29 Million SEK | -34.17% |
| 2010 Q4 | 6.29 Million SEK | 0.0% |
| 2009 FY | 9.56 Million SEK | -19.73% |
| 2008 FY | 11.92 Million SEK | -6.11% |
| 2007 FY | 12.69 Million SEK | 19.76% |
| 2006 FY | 10.6 Million SEK | 34.1% |
| 2005 FY | 7.9 Million SEK | 41.36% |
| 2004 FY | 5.59 Million SEK | 16.3% |
| 2003 FY | 4.8 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AddLife AB (publ) | 1.65 Billion SEK | 99.246% |
| Biotage AB (publ) | 437 Million SEK | 97.149% |
| Bonesupport Holding AB (publ) | 83.3 Million SEK | 85.044% |
| Doxa AB (publ) | - SEK | -Infinity% |
| Elekta AB (publ) | 3.25 Billion SEK | 99.618% |
| iZafe Group AB (publ) | 4.05 Million SEK | -207.478% |
| Ortivus AB (publ) | 12.45 Million SEK | 0.0% |
| Q-linea AB (publ) | 46.52 Million SEK | 73.222% |
| S2Medical AB (publ) | 4.09 Million SEK | -203.899% |
| Synsam AB (publ) | 707 Million SEK | 98.238% |